Literature DB >> 3557013

Protooncogene abnormalities in colon cancers and adenomatous polyps.

S J Meltzer, D J Ahnen, H Battifora, J Yokota, M J Cline.   

Abstract

To determine the frequency and clinical significance of oncogene abnormalities in colon cancer, deoxyribonucleic acids from 45 colon carcinomas and 15 benign adenomas were hybridized with 14 different protooncogene probes. Abnormalities of oncogenes were found in 22% of cancers at the time of resection. Amplification of c-myc or c-erbB-2 and allelic deletion of c-ras-Ha or c-myb were the most frequent abnormalities. The presence of altered oncogenes did not correlate with Dukes' stage, tumor progression, or patient survival after resection. One adenoma had an allelic deletion of the c-myb oncogene which was not seen in either the normal colon or an adjacent carcinoma. These data indicate that the spectrum of altered protooncogenes in colon carcinoma is similar to that of other adenocarcinomas, and that unstable oncogenes can be found before overt malignancy develops.

Entities:  

Mesh:

Year:  1987        PMID: 3557013     DOI: 10.1016/s0016-5085(87)91074-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.

Authors:  C Pothoulakis; R J Gilbert; C Cladaras; I Castagliuolo; G Semenza; Y Hitti; J S Montcrief; J Linevsky; C P Kelly; S Nikulasson; H P Desai; T D Wilkins; J T LaMont
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Oncogenes and gastrointestinal cancer.

Authors:  I Forgacs
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

Review 3.  Molecular biology of colorectal neoplasia.

Authors:  N Scott; P Quirke
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

4.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

5.  Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

Authors:  M Riegler; R Sedivy; C Pothoulakis; G Hamilton; J Zacherl; G Bischof; E Cosentini; W Feil; R Schiessel; J T LaMont
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.

Authors:  Ana I Robles; Giovanni Traverso; Ming Zhang; Nicholas J Roberts; Mohammed A Khan; Christine Joseph; Gregory Y Lauwers; Florin M Selaru; Maria Popoli; Meredith E Pittman; Xiquan Ke; Ralph H Hruban; Stephen J Meltzer; Kenneth W Kinzler; Bert Vogelstein; Curtis C Harris; Nickolas Papadopoulos
Journal:  Gastroenterology       Date:  2016-01-05       Impact factor: 22.682

Review 7.  Current status of tumor markers in large bowel cancer.

Authors:  M Moore; D J Jones; P F Schofield; D G Harnden
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

8.  A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.

Authors:  D J Jones; A K Ghosh; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

9.  Over-expression of the c-myc proto-oncogene in colorectal carcinoma.

Authors:  D R Smith; T Myint; H S Goh
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.